HEADER TRANSFERASE 24-FEB-16 5FX5 TITLE NOVEL INHIBITORS OF HUMAN RHINOVIRUS 3C PROTEASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: RHINOVIRUS 3C PROTEASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: 3C PROTEASE, RESIDUES 1508-1687; COMPND 5 EC: 2.4.22.28; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN RHINOVIRUS 2; SOURCE 3 ORGANISM_COMMON: HRV2; SOURCE 4 ORGANISM_TAXID: 12130; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.KAWATKAR,M.EK,V.HOESCH,M.GAGNON,E.NILSSON,T.LISTER,L.OLSSON, AUTHOR 2 J.PATEL,Q.YU REVDAT 3 09-OCT-24 5FX5 1 REMARK REVDAT 2 10-JAN-24 5FX5 1 REMARK LINK REVDAT 1 22-JUN-16 5FX5 0 JRNL AUTH S.P.KAWATKAR,M.GAGNON,V.HOESCH,C.TIONG-YIP,K.JOHNSON,M.EK, JRNL AUTH 2 E.NILSSON,T.LISTER,L.OLSSON,J.PATEL,Q.YU JRNL TITL DESIGN AND STRUCTURE-ACTIVITY RELATIONSHIPS OF NOVEL JRNL TITL 2 INHIBITORS OF HUMAN RHINOVIRUS 3C PROTEASE. JRNL REF BIOORG.MED.CHEM.LETT. V. 26 3248 2016 JRNL REFN ISSN 0960-894X JRNL PMID 27265257 JRNL DOI 10.1016/J.BMCL.2016.05.066 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 20849 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1057 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1405 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 182 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.38 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.18 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.79230 REMARK 3 B22 (A**2) : 0.28470 REMARK 3 B33 (A**2) : -2.07700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.220 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.112 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.108 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.135 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.103 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2996 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5372 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 707 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 41 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 433 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2996 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 1 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 199 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3418 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.18 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.60 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.61 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): -17.9596 2.6011 -9.2722 REMARK 3 T TENSOR REMARK 3 T11: 0.1192 T22: -0.0788 REMARK 3 T33: -0.0966 T12: 0.0106 REMARK 3 T13: -0.0012 T23: -0.0004 REMARK 3 L TENSOR REMARK 3 L11: 0.4395 L22: 1.9976 REMARK 3 L33: 0.5773 L12: 0.1277 REMARK 3 L13: -0.0175 L23: 0.0579 REMARK 3 S TENSOR REMARK 3 S11: -0.0414 S12: -0.0558 S13: -0.0244 REMARK 3 S21: -0.0454 S22: 0.0638 S23: 0.1075 REMARK 3 S31: -0.0036 S32: -0.0673 S33: -0.0224 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5FX5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-FEB-16. REMARK 100 THE DEPOSITION ID IS D_1290066284. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23481 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.560 REMARK 200 RESOLUTION RANGE LOW (A) : 77.640 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.2 REMARK 200 DATA REDUNDANCY : 12.40 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.56 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.65 REMARK 200 COMPLETENESS FOR SHELL (%) : 33.2 REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : 0.62000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2XYA REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG400, 100 MM TRIS-HCL PH 8.5, REMARK 280 200 MM MGCL2 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 35.29000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.81950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.29000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.81950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2179 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 32 -123.48 50.14 REMARK 500 LEU A 105 -61.27 -124.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 ETHYL (4R)-4-[[(2S, REMARK 600 3R)-1-[(2S)-3-METHYL-2-[(5-METHYLISOXAZOLE-3-CARBONYL)AMINO]BUTANOY REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PGE A 1184 REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1181 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1182 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 1183 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGE A 1184 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HOV A 1185 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FX6 RELATED DB: PDB REMARK 900 NOVEL INHIBITORS OF HUMAN RHINOVIRUS 3C PROTEASE DBREF 5FX5 A 1 180 UNP P04936 POLG_HRV2 1508 1687 SEQADV 5FX5 GLY A -1 UNP P04936 EXPRESSION TAG SEQADV 5FX5 SER A 0 UNP P04936 EXPRESSION TAG SEQRES 1 A 182 GLY SER GLY PRO GLU GLU GLU PHE GLY MET SER LEU ILE SEQRES 2 A 182 LYS HIS ASN SER CYS VAL ILE THR THR GLU ASN GLY LYS SEQRES 3 A 182 PHE THR GLY LEU GLY VAL TYR ASP ARG PHE VAL VAL VAL SEQRES 4 A 182 PRO THR HIS ALA ASP PRO GLY LYS GLU ILE GLN VAL ASP SEQRES 5 A 182 GLY ILE THR THR LYS VAL ILE ASP SER TYR ASP LEU TYR SEQRES 6 A 182 ASN LYS ASN GLY ILE LYS LEU GLU ILE THR VAL LEU LYS SEQRES 7 A 182 LEU ASP ARG ASN GLU LYS PHE ARG ASP ILE ARG ARG TYR SEQRES 8 A 182 ILE PRO ASN ASN GLU ASP ASP TYR PRO ASN CYS ASN LEU SEQRES 9 A 182 ALA LEU LEU ALA ASN GLN PRO GLU PRO THR ILE ILE ASN SEQRES 10 A 182 VAL GLY ASP VAL VAL SER TYR GLY ASN ILE LEU LEU SER SEQRES 11 A 182 GLY ASN GLN THR ALA ARG MET LEU LYS TYR SER TYR PRO SEQRES 12 A 182 THR LYS SER GLY TYR CYS GLY GLY VAL LEU TYR LYS ILE SEQRES 13 A 182 GLY GLN VAL LEU GLY ILE HIS VAL GLY GLY ASN GLY ARG SEQRES 14 A 182 ASP GLY PHE SER ALA MET LEU LEU ARG SER TYR PHE THR HET GOL A1181 6 HET GOL A1182 6 HET PG4 A1183 13 HET PGE A1184 7 HET HOV A1185 44 HETNAM GOL GLYCEROL HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM PGE TRIETHYLENE GLYCOL HETNAM HOV ETHYL (4R)-4-[[(2S,3R)-1-[(2S)-3-METHYL-2-[(5-METHYL-1, HETNAM 2 HOV 2-OXAZOL-3-YL)CARBONYLAMINO]BUTANOYL]-3-PHENYL- HETNAM 3 HOV PYRROLIDIN-2-YL]CARBONYLAMINO]-5-[(3S)-2- HETNAM 4 HOV OXIDANYLIDENEPYRROLIDIN-3-YL]PENTANOATE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 GOL 2(C3 H8 O3) FORMUL 4 PG4 C8 H18 O5 FORMUL 5 PGE C6 H14 O4 FORMUL 6 HOV C32 H43 N5 O7 FORMUL 7 HOH *182(H2 O) HELIX 1 1 GLY A 1 ASN A 14 1 14 HELIX 2 2 HIS A 40 ASP A 42 5 3 HELIX 3 3 ILE A 86 ILE A 90 5 5 HELIX 4 4 LEU A 175 PHE A 179 5 5 SHEET 1 AA 7 SER A 15 THR A 20 0 SHEET 2 AA 7 GLY A 23 TYR A 31 -1 O GLY A 23 N THR A 20 SHEET 3 AA 7 PHE A 34 PRO A 38 -1 O PHE A 34 N VAL A 30 SHEET 4 AA 7 LYS A 69 LEU A 77 -1 O THR A 73 N VAL A 37 SHEET 5 AA 7 ILE A 52 TYR A 63 -1 N ILE A 57 O LYS A 76 SHEET 6 AA 7 GLU A 46 VAL A 49 -1 O ILE A 47 N THR A 54 SHEET 7 AA 7 SER A 15 THR A 20 -1 O THR A 19 N GLN A 48 SHEET 1 AB 7 TYR A 97 LEU A 104 0 SHEET 2 AB 7 THR A 112 LEU A 127 -1 O THR A 112 N LEU A 104 SHEET 3 AB 7 ASN A 130 TYR A 138 -1 O ASN A 130 N LEU A 127 SHEET 4 AB 7 GLY A 169 MET A 173 -1 O GLY A 169 N TYR A 138 SHEET 5 AB 7 GLN A 156 GLY A 164 -1 O ILE A 160 N ALA A 172 SHEET 6 AB 7 VAL A 150 LYS A 153 -1 O LEU A 151 N LEU A 158 SHEET 7 AB 7 TYR A 97 LEU A 104 -1 O ASN A 101 N TYR A 152 LINK SG CYS A 147 C4 HOV A1185 1555 1555 1.83 SITE 1 AC1 3 TYR A 63 SER A 177 HOH A2084 SITE 1 AC2 4 LYS A 69 ASN A 130 HOH A2168 HOH A2178 SITE 1 AC3 6 GLU A 46 GLN A 48 THR A 53 SER A 121 SITE 2 AC3 6 TYR A 122 GLY A 123 SITE 1 AC4 1 TYR A 31 SITE 1 AC5 21 ASN A 22 LYS A 24 PHE A 25 HIS A 40 SITE 2 AC5 21 GLU A 71 LEU A 126 LEU A 127 SER A 128 SITE 3 AC5 21 THR A 142 LYS A 143 GLY A 145 TYR A 146 SITE 4 AC5 21 CYS A 147 HIS A 161 VAL A 162 GLY A 163 SITE 5 AC5 21 GLY A 164 ASN A 165 PHE A 170 HOH A2162 SITE 6 AC5 21 HOH A2181 CRYST1 70.580 77.639 34.134 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014168 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012880 0.000000 0.00000 SCALE3 0.000000 0.000000 0.029296 0.00000